Page last updated: 2024-08-23

mifepristone and Carcinoma, Lobular

mifepristone has been researched along with Carcinoma, Lobular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, M; Chen, J; Dong, DD; He, X; Li, K; Liu, J; Yang, H; Ye, SR; Yie, SM	1

Other Studies

1 other study(ies) available for mifepristone and Carcinoma, Lobular

Article	Year
HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro. Annals of surgical oncology, 2010, Volume: 17, Issue:5 Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Hormones; Humans; Immunoenzyme Techniques; In Vitro Techniques; Middle Aged; Mifepristone; Neoplasm Staging; Progesterone; Prognosis; Survival Rate; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured	2010

Article

Year

HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.

Annals of surgical oncology, 2010, Volume: 17, Issue:5

Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Hormones; Humans; Immunoenzyme Techniques; In Vitro Techniques; Middle Aged; Mifepristone; Neoplasm Staging; Progesterone; Prognosis; Survival Rate; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured

2010